Fighting Blindness Canada research

Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial

Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...

Read More